Form 4 for COLL COLLEGIUM PHARMACEUTICAL, INC

Accepted 2024-02-14 00:00:00 ET · period of report 2024-02-12 · accession 0001062993-24-003170 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2024-02-14	2024-02-12	COLL	Tupper Colleen	EVP, CFO	F - Tax	$33.70	-26.3K	160.0K	-14%	-$887.0K
M	2024-02-14	2024-02-12	COLL	Tupper Colleen	EVP, CFO	A - Grant	$0.00	+71.5K	146.0K	+96%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-02-12	F	D	9,453	$33.70	150,555	D	—	—	(F4) Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs.
2	Common	Common Stock	2024-02-12	A	A	30,856	$0.00	176,876	D	—	—	(F2) Effective February 12, 2024, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 30,856 performance share units ("PSUs") granted in the Issuer's three prior fiscal years.
3	Common	Common Stock	2024-02-12	A	A	40,600	$0.00	146,020	D	—	—	(F1) Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2025, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.
4	Common	Common Stock	2024-02-12	F	D	16,868	$33.70	160,008	D	—	—	(F3) Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs.